Disclosures for "Distinct Neuroimaging Profiles of Fast versus Slow Cognitive Decline across Diagnostic Stages in the UC Davis ADRC Cohort"
-
Dr. Agah has nothing to disclose.
-
Author has nothing to disclose
-
Mr. Johnson has nothing to disclose.
-
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
-
Dr. Mansour has nothing to disclose.
-
Dr. Maillard has nothing to disclose.